Experiences with
Avastin1,468 public posts
Want to take advantage of all our features? Just log in!
or
Webinar: New approved treatment for wet AMD
Lytenava (bevacizumab gamma), is the first licensed version of Avastin for wet age-related macular degeneration. The treatment was approved by the National Institute for Health and Care Excellence (NICE) for use in the NHS last year.